John H Johnson Insider Trading $PTLA PORTOLA PHARMACEUTICALS INC
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
John H Johnson in PORTOLA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John H Johnson in PORTOLA PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | D | 0.00 | 54,991 | 0 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | D | 17.94 | 11,377 | 204,103 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 7,281 | 131,058 | 0 | 7.3 K to 0 (-100.00 %) |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 13,194 | 237,492 | 0 | 13.2 K to 0 (-100.00 %) |
| Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 17.94 | 11,377 | 204,103 | 11,377 | |
| Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 7,281 | 0 | 20,475 | 13.2 K to 20.5 K (+55.18 %) |
| Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 26.09 | 6,991 | 182,395 | 6,991 | |
| Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 4,194 | 0 | 13,194 | 9 K to 13.2 K (+46.60 %) |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
| Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
| Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 35.06 | 6,000 | 210,360 | 6,000 | |
| Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | JOHNSON JOHN | Director | Option Exercise | A | 44.39 | 10,000 | 443,900 | 10,000 |
Page: 1